Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Matthew Anaka"'
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100985- (2021)
We propose a new process for peer review of multidisciplinary journal submissions called ‘segmented peer review’. The current translational research environment increasingly requires complex and multidisciplinary studies that span multiple distin
Externí odkaz:
https://doaj.org/article/cf0ebb1b00b64465b1132762845bae60
Autor:
Lu Cao, Prashanth Prithviraj, Ritu Shrestha, Revati Sharma, Matthew Anaka, Kim R. Bridle, George Kannourakis, Darrell H.G. Crawford, Aparna Jayachandran
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 10, p 2191 (2021)
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily increasing incidence and poor prognosis. Ongoing clinical trials are assessing the effectiveness and safety of a few immune checkpoint inhibitors (ICIs) in CCA patients.
Externí odkaz:
https://doaj.org/article/5f9901f31b284c93b095e499384d804a
Autor:
Ritu Shrestha, Prashanth Prithviraj, Matthew Anaka, Kim R. Bridle, Darrell H. G. Crawford, Bijay Dhungel, Jason C. Steel, Aparna Jayachandran
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
The global burden of hepatocellular carcinoma (HCC), one of the frequent causes of cancer-related deaths worldwide, is rapidly increasing partly due to the limited treatment options available for this disease and recurrence due to therapy resistance.
Externí odkaz:
https://doaj.org/article/7905da4da4b343cd9f6c63f9813f89e4
Autor:
Daniel G. Hurley, Jonathan Cebon, Joseph Cursons, Andreas Behren, Matthew Anaka, Miles C. Andrews, Edmund J. Crampin
Publikováno v:
Molecular Cancer
Background In many cancers, microRNAs (miRs) contribute to metastatic progression by modulating phenotypic reprogramming processes such as epithelial-mesenchymal plasticity. This can be driven by miRs targeting multiple mRNA transcripts, inducing reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fb94476aa043e046d2932dea649e522
Publikováno v:
JCO oncology practice. 18(6)
PURPOSE: Goals of care (GoC) designations are an important part of advanced care planning (ACP) for patients with incurable cancers. Studies of outpatient oncology records show that most patients do not have GoC documented. We performed a retrospecti
Autor:
Matthew Anaka, Prashanth Prithviraj, Andreas Behren, George Kannourakis, Marzena Walkiewicz, Candani Tutuka, Aparna Jayachandran, Erik W. Thompson, Revati Sharma
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports
Scientific Reports
Elevated levels of pregnancy-associated plasma protein-A (PAPP-A) have been implicated in the pathogenesis of various malignancies, including breast cancers. Breast cancer is one of the most frequent carcinomas and is the second most common cancer ty
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 2, Pp 100985-(2021)
Translational Oncology, Vol 14, Iss 2, Pp 100985-(2021)
Highlights • Segmented peer review is a new process for multidisciplinary research submissions • It explicitly allocates segments of a manuscript to appropriate expert reviewers • Reviewers focus on segments of the manuscript within their speci
Autor:
Nicole Crisp, Matthew Anaka, Michael Patvin Chu, Anthea Peters, Christopher P. Venner, Irwindeep Sandhu, Shyam Ravisankar, Nan Cox-Kennett
Publikováno v:
Transplantation and Cellular Therapy. 27:S374-S375
Autor:
Darrell H. G. Crawford, Ritu Shrestha, Prashanth Prithviraj, Kim R. Bridle, Aparna Jayachandran, George Kannourakis, Lu Cao, Matthew Anaka, Revati Sharma
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 10
Journal of Clinical Medicine, Vol 10, Iss 2191, p 2191 (2021)
Volume 10
Issue 10
Journal of Clinical Medicine, Vol 10, Iss 2191, p 2191 (2021)
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily increasing incidence and poor prognosis. Ongoing clinical trials are assessing the effectiveness and safety of a few immune checkpoint inhibitors (ICIs) in CCA patients.
Autor:
Joseph Perera, Simon Raphael, Parneet Cheema, Ines B Menjak, Sunil Verma, Matthew Anaka, Nevkeet Toor, Susanna Y Cheng, Ryan Freedman, Zoe Winterton-Perks, J. Charles Victor, Ahmad Muinuddin
Publikováno v:
Journal of Oncology Practice. 13:e130-e138
Purpose: Optimal first-line systemic therapy for patients with advanced nonsquamous (nonsq) non–small-cell lung cancer (NSCLC) requires confirmation of EGFR/ ALK status, which can delay treatment. We evaluated the impact of reflex testing, defined